Quantcast
Home / IBR Headlines / AstraZeneca to pay state of Idaho $2.5 million for overpricing (access required)

AstraZeneca to pay state of Idaho $2.5 million for overpricing (access required)

AstraZeneca has agreed to pay $2.5 million in a legal settlement with the state of Idaho over the cost of drugs for the state’s Medicaid program. The state bases its reimbursement rates to pharmacies for prescription drugs on the “average wholesale price” reported by drug manufacturers. “Where published prices are false or misleading, the taxpayers are significantly ...

About IBR Contributor